Skip to main content

Featured

Nerve Block Therapy Offers Hope for Migraine Sufferers

                           Calgary neurologist Dr. Serena Orr injecting a patient to help treat migraines.  Researchers in Calgary are spotlighting a promising treatment for people living with severe migraines: occipital nerve blocks . This approach involves injecting a small amount of anesthetic near the occipital nerves at the back of the head, which can interrupt pain signals and provide rapid relief. Neurologist Dr. Serena Orr of the University of Calgary has been at the forefront of this research, recommending updates to the American Headache Society’s guidelines for emergency departments. The new recommendations encourage doctors to consider nerve blocks as a frontline option for patients arriving with debilitating migraine attacks. Patients who have received the treatment report significant improvement. Some describe it as the first time they’ve been able to escape the crushing pain, nausea,...
Post a Comment
Read more

article

Labels

Stock Market Today: Dow, S&P 500, Nasdaq Rebound Amid China Tariff Retaliation and New Jobs Data

                                    

US stocks rebounded on Tuesday as investors assessed China's swift retaliation to the latest US tariffs and digested fresh jobs data. The Dow Jones Industrial Average rose by 0.2%, while the S&P 500 gained 0.7%, and the tech-heavy Nasdaq Composite jumped 1.2%.

China responded to the new 10% tariffs imposed by the US with tariffs of its own on US coal, liquified natural gas, crude oil, farm equipment, and some autos. Despite the escalating trade tensions, some analysts see China's measured response as a potential opening for compromise.

Meanwhile, job openings in the US declined more than expected in December, adding to concerns about the labor market's cooling trend. Investors are closely watching these developments as the Federal Reserve considers future interest rate cuts amid ongoing inflation concerns.

Tech stocks led the gains, with Alphabet (Google) shares rising nearly 2% ahead of its fourth-quarter earnings report. Vaccine stocks, however, fell after Robert F. Kennedy Jr.'s nomination to lead the Health and Human Services Department advanced to the Senate.

Overall, the market's positive reaction suggests cautious optimism as traders navigate the complexities of trade relations and economic data.



Labels:

Comments

Post a Comment